STAT

Opinion: Will the newest pill for HIV prevention fuel progress — or profits?

"Getting to Zero" — meaning zero new HIV infections — is a great goal. For Gilead Sciences, the maker of the only two FDA-approved pills for PrEP, the most important…
Decovy and Truvada are only two FDA-approved pills for PrEP.

Four decades after the HIV epidemic began, there’s finally hope it might end. Indeed, “Getting to Zero” — meaning zero new HIV infections — is a slogan used by the World Health Organization and others in fighting the epidemic.

A major factor driving this optimism is pre-exposure prophylaxis, commonly known as PrEP, in which people who are HIV-negative take a medication to prevent HIV infection.

For Gilead Sciences, the manufacturer of the only two FDA-approved pills for PrEP, the most important zeroes seem to be those the company is adding to its .

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Gene Therapies For Deafness Dredge Up An Old Question: Do Deaf People Want A ‘Cure’?
As scientists celebrate gene therapy's ability to enable hearing, deaf people are feeling a familiar dread: Are we endangered?
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Merck Deal, Weight Loss Drugs, And Lots More
Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing market for eye care.
STAT1 min read
STAT+: Akili, Maker Of A Video Game To Treat ADHD, To Be Acquired For $34 Million
Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics.

Related Books & Audiobooks